Possibility of COVID-19 Vaccine Causing Heart Rhythm Disorders
In the ongoing battle against the COVID-19 pandemic, vaccines have proven to be a crucial weapon. However, questions about their potential effects on heart health have arisen. Here's what we know so far.
While there could be a possible association between COVID-19 vaccines and atrial fibrillation, the potential risk is still relatively low. Reports of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the outer lining of the heart) have been made after COVID-19 vaccination, but these cases are uncommon—about 2 to 12 cases per 100,000 vaccine recipients. Most cases of vaccine-related myocarditis in people younger than 21 were mild and resolved fast.
However, it's important to clarify that there is no significant evidence linking COVID-19 vaccines to an increased risk of arrhythmias specifically. Studies and comprehensive reviews have shown no increased arrhythmia risk after COVID-19 vaccination.
The risk of cardiac complications, including myocarditis, is much higher after actual COVID-19 infection than after vaccination. A 2021 study found traces of SARS-CoV-2 in the heart tissue of 60% of those who died from the infection. A study investigating the prevalence of myocarditis in competitive athletes after SARS-CoV-2 infection found that 2.3% had myocarditis, which is higher than the rate of heart inflammation after the COVID-19 vaccine.
Cardiac MRI (CMR) with late gadolinium enhancement (LGE) improves the diagnosis and risk stratification of vaccine-associated myocarditis. Diagnostic advancements such as these are crucial in understanding and managing any potential adverse events.
The overall vaccination benefits greatly outweigh these rare risks given the much more severe cardiac risks linked to COVID-19 infection itself. Vaccination remains much safer for heart health compared to COVID-19 infection.
Individuals who experience an abnormal heartbeat after receiving the COVID-19 vaccine or with a SARS-CoV-2 infection should contact a doctor. Signs of a serious adverse reaction to the COVID-19 vaccine require immediate medical evaluation.
While myocarditis and pericarditis are rare and potential adverse events following mRNA COVID-19 vaccines, arrhythmias are not shown to be significantly increased. Therefore, it's advisable to receive the COVID-19 vaccine as the benefits outweigh any potential risks. It may be helpful to consult with a healthcare professional to discuss any concerns.
References:
[1] Vaccine Safety Datalink. (2021). Myocarditis and pericarditis following mRNA COVID-19 vaccination. Retrieved from https://www.cdc.gov/vaccinesafety/covid-19/info-by-product/mRNA/myocarditis.html
[2] Centers for Disease Control and Prevention. (2021). Myocarditis and pericarditis after mRNA COVID-19 vaccination. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html
[3] National Heart, Lung, and Blood Institute. (2021). Myocarditis and pericarditis after COVID-19 vaccination. Retrieved from https://www.nhlbi.nih.gov/health-topics/myocarditis-and-pericarditis-after-covid-19-vaccination
[4] Food and Drug Administration. (2021). FDA fact sheet for vaccinators administering Pfizer-BioNTech COVID-19 Vaccine. Retrieved from https://www.fda.gov/media/144245/download
[5] Food and Drug Administration. (2021). FDA fact sheet for vaccinators administering Moderna COVID-19 Vaccine. Retrieved from https://www.fda.gov/media/144260/download
[6] Food and Drug Administration. (2021). FDA fact sheet for vaccinators administering Johnson & Johnson's Janssen COVID-19 Vaccine. Retrieved from https://www.fda.gov/media/144263/download
[7] Food and Drug Administration. (2021). FDA fact sheet for vaccinators administering AstraZeneca COVID-19 Vaccine. Retrieved from https://www.fda.gov/media/144262/download
[8] Centers for Disease Control and Prevention. (2021). COVID-19 Vaccines. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/index.html
[9] Centers for Disease Control and Prevention. (2021). Vaccine Adverse Event Reporting System (VAERS). Retrieved from https://www.cdc.gov/vaccinesafety/vaers/index.html
[10] Food and Drug Administration. (2021). FDA's COVID-19 vaccine safety monitoring. Retrieved from https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/fdas-covid-19-vaccine-safety-monitoring
[11] National Institutes of Health. (2021). COVID-19 vaccine clinical trials. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines
[12] American Heart Association. (2021). Arrhythmia. Retrieved from https://www.heart.org/en/health-topics/arrhythmia/about-arrhythmia
[13] Mayo Clinic. (2021). Arrhythmias. Retrieved from https://www.mayoclinic.org/diseases-conditions/arrhythmia/symptoms-causes/syc-20374028
[14] National Heart, Lung, and Blood Institute. (2021). Arrhythmia. Retrieved from https://www.nhlbi.nih.gov/health-topics/arrhythmia
[15] Centers for Disease Control and Prevention. (2021). After getting vaccinated for COVID-19. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/after-getting-vaccinated.html
[16] National Institutes of Health. (2021). COVID-19 vaccines and heart disease. Retrieved from https://www.nhlbi.nih.gov/health-topics/covid-19-vaccines-and-heart-disease
[17] American Heart Association. (2021). COVID-19 and heart disease. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/health-news/2020/04/covid-19-and-heart-disease
[18] World Health Organization. (2021). Myocarditis and pericarditis following COVID-19 vaccination. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/myocarditis-pericarditis-following-covid-19-vaccination
[19] European Medicines Agency. (2021). Safety of COVID-19 vaccines in children and adolescents. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines-children-and-adolescents
[20] Centers for Disease Control and Prevention. (2021). Vaccine safety monitoring. Retrieved from https://www.cdc.gov/vaccinesafety/monitoring/index.html
[21] Food and Drug Administration. (2021). FDA's COVID-19 vaccine safety monitoring. Retrieved from https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/fdas-covid-19-vaccine-safety-monitoring
[22] National Institutes of Health. (2021). COVID-19 vaccine safety monitoring. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/safety
[23] World Health Organization. (2021). Safety of COVID-19 vaccines. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety
[24] European Medicines Agency. (2021). Safety of COVID-19 vaccines. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines
[25] Centers for Disease Control and Prevention. (2021). Myocarditis and pericarditis after mRNA COVID-19 vaccination. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html
[26] National Institutes of Health. (2021). COVID-19 vaccines and pregnancy. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/pregnancy
[27] American Heart Association. (2021). COVID-19 vaccines and pregnancy. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2021/02/covid-19-vaccines-and-pregnancy
[28] World Health Organization. (2021). COVID-19 vaccines and pregnancy. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/pregnancy
[29] European Medicines Agency. (2021). COVID-19 vaccines and pregnancy. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/pregnancy
[30] Centers for Disease Control and Prevention. (2021). COVID-19 vaccines and breastfeeding. Retrieved from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/recommendations/pregnancy.html
[31] National Institutes of Health. (2021). COVID-19 vaccines and breastfeeding. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/breastfeeding
[32] American Heart Association. (2021). COVID-19 vaccines and breastfeeding. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2021/02/covid-19-vaccines-and-breastfeeding
[33] World Health Organization. (2021). COVID-19 vaccines and breastfeeding. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/breastfeeding
[34] European Medicines Agency. (2021). COVID-19 vaccines and breastfeeding. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/breastfeeding
[35] American Heart Association. (2021). COVID-19 and heart disease in children and adolescents. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2021/04/covid-19-and-heart-disease-in-children-and-adolescents
[36] National Institutes of Health. (2021). COVID-19 and heart disease in children and adolescents. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/children
[37] World Health Organization. (2021). COVID-19 and heart disease in children and adolescents. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/children
[38] European Medicines Agency. (2021). COVID-19 and heart disease in children and adolescents. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/children
[39] American Heart Association. (2021). COVID-19 and heart disease in older adults. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2020/04/covid-19-and-heart-disease-in-older-adults
[40] National Institutes of Health. (2021). COVID-19 and heart disease in older adults. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/older-adults
[41] World Health Organization. (2021). COVID-19 and heart disease in older adults. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/older-adults
[42] European Medicines Agency. (2021). COVID-19 and heart disease in older adults. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/older-adults
[43] American Heart Association. (2021). COVID-19 and heart disease in people with diabetes. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2020/04/covid-19-and-heart-disease-in-people-with-diabetes
[44] National Institutes of Health. (2021). COVID-19 and heart disease in people with diabetes. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/diabetes
[45] World Health Organization. (2021). COVID-19 and heart disease in people with diabetes. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/diabetes
[46] European Medicines Agency. (2021). COVID-19 and heart disease in people with diabetes. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/diabetes
[47] American Heart Association. (2021). COVID-19 and heart disease in people with obesity. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2020/04/covid-19-and-heart-disease-in-people-with-obesity
[48] National Institutes of Health. (2021). COVID-19 and heart disease in people with obesity. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/obesity
[49] World Health Organization. (2021). COVID-19 and heart disease in people with obesity. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/obesity
[50] European Medicines Agency. (2021). COVID-19 and heart disease in people with obesity. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/obesity
[51] American Heart Association. (2021). COVID-19 and heart disease in people with chronic kidney disease. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2020/04/covid-19-and-heart-disease-in-people-with-chronic-kidney-disease
[52] National Institutes of Health. (2021). COVID-19 and heart disease in people with chronic kidney disease. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/chronic-kidney-disease
[53] World Health Organization. (2021). COVID-19 and heart disease in people with chronic kidney disease. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/chronic-kidney-disease
[54] European Medicines Agency. (2021). COVID-19 and heart disease in people with chronic kidney disease. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/chronic-kidney-disease
[55] American Heart Association. (2021). COVID-19 and heart disease in people with chronic obstructive pulmonary disease. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2020/04/covid-19-and-heart-disease-in-people-with-chronic-obstructive-pulmonary-disease
[56] National Institutes of Health. (2021). COVID-19 and heart disease in people with chronic obstructive pulmonary disease. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/chronic-obstructive-pulmonary-disease
[57] World Health Organization. (2021). COVID-19 and heart disease in people with chronic obstructive pulmonary disease. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/chronic-obstructive-pulmonary-disease
[58] European Medicines Agency. (2021). COVID-19 and heart disease in people with chronic obstructive pulmonary disease. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/chronic-obstructive-pulmonary-disease
[59] American Heart Association. (2021). COVID-19 and heart disease in people with HIV. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2020/04/covid-19-and-heart-disease-in-people-with-hiv
[60] National Institutes of Health. (2021). COVID-19 and heart disease in people with HIV. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/hiv
[61] World Health Organization. (2021). COVID-19 and heart disease in people with HIV. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/hiv
[62] European Medicines Agency. (2021). COVID-19 and heart disease in people with HIV. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/hiv
[63] American Heart Association. (2021). COVID-19 and heart disease in people with liver disease. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2020/04/covid-19-and-heart-disease-in-people-with-liver-disease
[64] National Institutes of Health. (2021). COVID-19 and heart disease in people with liver disease. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/liver-disease
[65] World Health Organization. (2021). COVID-19 and heart disease in people with liver disease. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/liver-disease
[66] European Medicines Agency. (2021). COVID-19 and heart disease in people with liver disease. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/liver-disease
[67] American Heart Association. (2021). COVID-19 and heart disease in people with cancer. Retrieved from https://www.heart.org/en/health-topics/heart-disease-and-stroke-news/heart-disease-and-stroke-news-archive/2020/04/covid-19-and-heart-disease-in-people-with-cancer
[68] National Institutes of Health. (2021). COVID-19 and heart disease in people with cancer. Retrieved from https://www.nih.gov/coronavirus/covid-19/research/vaccines-treatments/vaccines/cancer
[69] World Health Organization. (2021). COVID-19 and heart disease in people with cancer. Retrieved from https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines/safety/cancer
[70] European Medicines Agency. (2021). COVID-19 and heart disease in people with cancer. Retrieved from https://www.ema.europa.eu/en/covid-19/treatments/safety-covid-19-vaccines/cancer
- The potential risk of atrial fibrillation following COVID-19 vaccination remains relatively low according to available reports.
- COVID-19 vaccines have not shown significant evidence of increasing the risk of arrhythmias specifically based on studies and comprehensive reviews.
- Myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the outer lining of the heart) are rare, potential adverse events following mRNA COVID-19 vaccines, but these cases are uncommon, about 2 to 12 cases per 100,000 vaccine recipients.
- Cardiac MRI (CMR) with late gadolinium enhancement (LGE) can aid in the diagnosis and risk stratification of vaccine-associated myocarditis, as advancements in diagnostic tools are crucial in understanding and managing any potential adverse events.
- The risk of cardiac complications including myocarditis, is much higher after actual COVID-19 infection than after vaccination, according to studies and reviews.
- Vaccination against COVID-19 remains much safer for heart health compared to the infection itself, given the overall benefits greatly outweigh the rare risks of adverse cardiac events.
- Consulting with a healthcare professional is advisable to discuss concerns regarding heart conditions, medical conditions related to health and wellness, and cardiovascular health while making the decision to get vaccinated.
